BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8720715)

  • 21. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of MHC class II antigen in cultured bovine ciliary epithelial cells.
    Helbig H; Gurley RC; Reichl RJ; Mahdi R; Nussenblatt RB; Palestine AG
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):556-61. PubMed ID: 2125019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of MHC-matched corneal allografts in Th1-deficient hosts.
    Hargrave SL; Hay C; Mellon J; Mayhew E; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1188-93. PubMed ID: 15037587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
    Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid method for successful HLA class I and II typing from cadaveric blood for direct matching in cornea transplantation.
    Wernet P; Kögler G; Enczmann J; Kuhröber A; Knipper AJ; Bonte W; Reinhard T; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 1998 Jul; 236(7):507-12. PubMed ID: 9672796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies.
    Hosenpud JD; Shipley GD; Morris TE; Hefeneider SH; Wagner CR
    Transplantation; 1993 Feb; 55(2):405-11. PubMed ID: 7679530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-based HLA class II postmortem typing: evaluation of different techniques for prospective corneal allografting.
    Jenisch S; Westphal E; Zavazava N; Dürr C; Duncker G; Nölle B; Müller-Ruchholtz W
    Graefes Arch Clin Exp Ophthalmol; 1995 Oct; 233(10):635-41. PubMed ID: 8529907
    [No Abstract]   [Full Text] [Related]  

  • 30. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
    Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
    Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA DR and DQ expression on human retinal pigment epithelial cells in vitro.
    Baudouin C; Fredj-Reygrobellet D; Jambou D; Gastaud P; Lapalus P
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(1):86-9. PubMed ID: 2107128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Culture in vitro modulation of human leukocyte antigen molecules and costimulatory molecules on human retinal pigment epithelium.
    Xie MS; Xu GX
    Ophthalmologica; 2008; 222(1):48-52. PubMed ID: 18097181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal graft survival in HLA-A- and HLA-B-matched transplantations in high-risk cases with retrospective review of HLA-DR compatibility.
    Beekhuis WH; van Rij G; Renardel de Lavalette JG; Rinkel-van Driel E; Persijn G; D'Amaro J
    Cornea; 1991 Jan; 10(1):9-12. PubMed ID: 2019116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matching for Human Leukocyte Antigens (HLA) in corneal transplantation - to do or not to do.
    van Essen TH; Roelen DL; Williams KA; Jager MJ
    Prog Retin Eye Res; 2015 May; 46():84-110. PubMed ID: 25601193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.
    Bartels MC; Otten HG; van Gelderen BE; Van der Lelij A
    Br J Ophthalmol; 2001 Nov; 85(11):1341-6. PubMed ID: 11673303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group.
    Hahn AB; Foulks GN; Enger C; Fink N; Stark WJ; Hopkins KA; Sanfilippo F
    Transplantation; 1995 Jan; 59(1):21-7. PubMed ID: 7839424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual analysis of expected time on the waiting list for HLA-matched corneal grafts.
    Böhringer D; Reinhard T; Enczmann J; Godehard E; Sundmacher R
    Dev Ophthalmol; 2003; 36():50-5. PubMed ID: 12494680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.